Company · CIK 1636651
Ovid Therapeutics Inc.
| CIK | 1636651 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | OVID (Nasdaq) |
| First annual or quarterly report | 2017-06-13 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295218 | 2026-04-21 | 2026-04-24 | 2 | |
| 333-292151 | 2025-12-15 | 2025-12-22 | 2 | |
| 333-275307 | 2023-11-03 | 2023-11-15 | 3 | |
| 333-250054 | 2020-11-13 | 2020-11-20 | 3 | |
| 333-225391 | 2018-06-01 | 2020-08-26 | 12 | |
| 333-217245 | 2017-04-10 | 2017-05-05 | 7 |
Filings
30| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-24 | EFFECTDeclared effective | 333-295218 | 9999999995-26-001333 |
| 2026-04-21 | S-3Shelf registered | 333-295218 | 0001193125-26-166974 |
| 2025-12-22 | EFFECTDeclared effective | 333-292151 | 9999999995-25-003891 |
| 2025-12-15 | S-3Shelf registered | 333-292151 | 0001193125-25-319453 |
| 2023-11-15 | EFFECTDeclared effective | 333-275307 | 9999999995-23-003334 |
| 2023-11-15 | 424B5Shelf takedown | 333-275307 | 0001193125-23-277893 |
| 2023-11-03 | S-3Shelf registered | 333-275307 | 0001193125-23-270373 |
| 2020-11-20 | EFFECTDeclared effective | 333-250054 | 9999999995-20-003262 |
| 2020-11-20 | 424B5Shelf takedown | 333-250054 | 0001193125-20-299425 |
| 2020-11-13 | S-3Shelf registered | 333-250054 | 0001193125-20-292202 |
| 2020-08-26 | 424B5Shelf takedown | 333-225391 | 0001193125-20-231241 |
| 2019-11-12 | 424B5Shelf takedown | 333-225391 | 0001193125-19-289308 |
| 2019-10-08 | 424B5Shelf takedown | 333-225391 | 0001193125-19-263978 |
| 2019-10-08 | 424B5Shelf takedown | 333-225391 | 0001193125-19-263977 |
| 2019-10-03 | 424B5Shelf takedown | 333-225391 | 0001193125-19-261653 |
| 2019-10-03 | 424B5Shelf takedown | 333-225391 | 0001193125-19-261644 |
| 2019-02-22 | 424B5Shelf takedown | 333-225391 | 0001193125-19-047382 |
| 2019-02-22 | 424B5Shelf takedown | 333-225391 | 0001193125-19-047374 |
| 2019-02-19 | 424B5Shelf takedown | 333-225391 | 0001193125-19-044216 |
| 2019-02-19 | 424B5Shelf takedown | 333-225391 | 0001193125-19-044207 |
| 2018-06-19 | EFFECTDeclared effective | 333-225391 | 9999999995-18-001543 |
| 2018-06-01 | S-3Shelf registered | 333-225391 | 0001193125-18-181948 |
| 2017-05-05 | 424B4Final prospectus | 333-217245 | 0001193125-17-160655 |
| 2017-05-04 | EFFECTDeclared effective | 333-217245 | 9999999995-17-001185 |
| 2017-05-03 | S-1/AAmendment | 333-217245 | 0001193125-17-155688 |
| 2017-05-02 | S-1/AAmendment | 333-217245 | 0001193125-17-152270 |
| 2017-04-25 | S-1/AAmendment | 333-217245 | 0001193125-17-135563 |
| 2017-04-18 | S-1/AAmendment | 333-217245 | 0001193125-17-127476 |
| 2017-04-10 | S-1Registration filed | 333-217245 | 0001193125-17-118846 |
| 2017-02-03 | DRSDraft made public | 377-01486 | 0000950123-17-000739 |